Objectives. To investigate whether a reduction in the O2 tension from 5 to 2% during extended culture from day 3 onwards was beneficial to human blastocyst development in vitro. Methods. We firstly identified 139 patients who had no low-quality embryos on day 3, and all the embryos were prolonged to culture on day 5 or 6. We mainly analyzed 188 patients receiving IVF/ICSI-ET for the first time, and no high-quality embryos were obtained on day 3 from January 2018 to December 2019. After transferred with one or two low-quality embryos, extended culture was performed under low O2 (5%) or ultralow O2 (2%) tension for surplus embryos. 296 embryos from 106 patients were continued to culture under 5% O2 tension, and 214 embryos from 82 patients were continued to culture under 2% O2 tension. Main outcomes compared were blastulation and high-quality blastulation rates. Results. We observed no significant differences in the blastulation and high-quality blastulation rates for high-quality cleavage-stage embryos between 2% and 5% O2 groups ( p > 0.05 ). For low-quality cleavage-stage embryos, we observed that the 2% O2 group showed a significantly higher blastulation (39.72 versus 31.08%; p = 0.043 ) rate than that in the 5% O2 group. The high-quality blastocyst formation rate (10.75 versus 8.45%; p = 0.380 ) was comparable between the 2% and 5% O2 groups. The blastulation rate reached 44.86% by culturing blastocysts an additional day under 2% O2 tension which was significantly higher than that (32.09%) under 5% O2 tension ( p < 0.05 ). Conclusion. A reduction in O2 tension from 5 to 2% after day 3 might be beneficial to the patients with no high-quality embryos. Extended culture to day 7 under 2% O2 tension increased the number of available blastocysts per IVF/ICSI cycle and was worth recommending especially for patients with few blastocysts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.